Literature DB >> 16497735

Should obese women with polycystic ovary syndrome receive treatment for infertility?

Adam H Balen, Martin Dresner, Eleanor M Scott, James O Drife.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16497735      PMCID： PMC1382524          DOI： 10.1136/bmj.332.7539.434

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  9 in total

1.  Impaired glucose tolerance in pregnant women with polycystic ovary syndrome.

Authors:  P A Radon; M J McMahon; W R Meyer
Journal:  Obstet Gynecol       Date:  1999-08       Impact factor: 7.661

2.  Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study.

Authors:  Thomas Tang; Julie Glanville; Catherine J Hayden; Davinia White; Julian H Barth; Adam H Balen
Journal:  Hum Reprod       Date:  2005-09-30       Impact factor: 6.918

Review 3.  Effects of obesity on women's reproduction and complications during pregnancy.

Authors:  Y Linné
Journal:  Obes Rev       Date:  2004-08       Impact factor: 9.213

Review 4.  What is polycystic ovary syndrome? Are national views important?

Authors:  Adam Balen; Kathy Michelmore
Journal:  Hum Reprod       Date:  2002-09       Impact factor: 6.918

Review 5.  Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome.

Authors:  J M Lord; I H K Flight; R J Norman
Journal:  Cochrane Database Syst Rev       Date:  2003

Review 6.  Improving reproductive performance in overweight/obese women with effective weight management.

Authors:  Robert J Norman; Manny Noakes; Ruijin Wu; Michael J Davies; Lisa Moran; Jim X Wang
Journal:  Hum Reprod Update       Date:  2004 May-Jun       Impact factor: 15.610

7.  Maternal morbid obesity and the risk of adverse pregnancy outcome.

Authors:  Marie I Cedergren
Journal:  Obstet Gynecol       Date:  2004-02       Impact factor: 7.661

8.  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.

Authors: 
Journal:  Fertil Steril       Date:  2004-01       Impact factor: 7.329

9.  Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss.

Authors:  R Pasquali; D Antenucci; F Casimirri; S Venturoli; R Paradisi; R Fabbri; V Balestra; N Melchionda; L Barbara
Journal:  J Clin Endocrinol Metab       Date:  1989-01       Impact factor: 5.958
  9 in total
  15 in total

1.  Drugs for anovulatory infertility in polycystic ovary syndrome.

Authors:  Hesham Al-Inany; Neil Johnson
Journal:  BMJ       Date:  2006-06-24

Review 2.  Managing anovulatory infertility and polycystic ovary syndrome.

Authors:  Adam H Balen; Anthony J Rutherford
Journal:  BMJ       Date:  2007-09-29

3.  Obesity, polycystic ovary syndrome, infertility treatment: lifestyle modification is paramount.

Authors:  Jonathan M Lord; Robert Norman
Journal:  BMJ       Date:  2006-03-11

4.  Obesity, polycystic ovary syndrome, infertility treatment: asking obese women to lose weight before treatment increases stigmatisation.

Authors:  Sheila E Laredo
Journal:  BMJ       Date:  2006-03-11

5.  Body mass index and short-term weight change in relation to treatment outcomes in women undergoing assisted reproduction.

Authors:  Jorge E Chavarro; Shelley Ehrlich; Daniela S Colaci; Diane L Wright; Thomas L Toth; John C Petrozza; Russ Hauser
Journal:  Fertil Steril       Date:  2012-05-16       Impact factor: 7.329

Review 6.  Metformin use in women with polycystic ovary syndrome.

Authors:  Neil P Johnson
Journal:  Ann Transl Med       Date:  2014-06

7.  Greater exercise sweating in obese women with polycystic ovary syndrome compared with obese controls.

Authors:  Nina S Stachenfeld; Catherine Weikart Yeckel; Hugh S Taylor
Journal:  Med Sci Sports Exerc       Date:  2010-09       Impact factor: 5.411

8.  The LIFESTYLE study: costs and effects of a structured lifestyle program in overweight and obese subfertile women to reduce the need for fertility treatment and improve reproductive outcome. A randomised controlled trial.

Authors:  Meike A Q Mutsaerts; Henk Groen; Nancy C W ter Bogt; Johanna H T Bolster; Jolande A Land; Wanda J E Bemelmans; Walter K H Kuchenbecker; Peter G A Hompes; Nick S Macklon; Ronald P Stolk; Fulco van der Veen; Jacques W M Maas; Nicole F Klijn; Eugenie M Kaaijk; Gerrit J E Oosterhuis; Peter X J M Bouckaert; Jaap M Schierbeek; Yvonne M van Kasteren; Annemiek W Nap; Frank J Broekmans; Egbert A Brinkhuis; Carolien A M Koks; Jan M Burggraaff; Adrienne S Blankhart; Denise A M Perquin; Marie H Gerards; Robert J A B Mulder; Ed T C M Gondrie; Ben W J Mol; Annemieke Hoek
Journal:  BMC Womens Health       Date:  2010-06-25       Impact factor: 2.809

9.  Should access to fertility-related services be conditional on body mass index?

Authors:  Anjel Vahratian; Yolanda R Smith
Journal:  Hum Reprod       Date:  2009-03-11       Impact factor: 6.918

10.  Health related quality of life among different PCOS phenotypes of infertile women.

Authors:  Berna Dilbaz; Mehmet Cınar; Enis Ozkaya; Nazan Vanlı Tonyalı; Serdar Dilbaz
Journal:  J Turk Ger Gynecol Assoc       Date:  2012-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.